FindTrial
Sign In

The effect of bariatric surgery on the pharmacokinetics of venlafaxine

The effect of bariatric surgery on the pharmacokinetics of venlafaxine - VENLA study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47961
Enrollment
12
Registered
2019-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bariatrische chirurgie Bariatric surgery

Interventions

None listed

Sponsors

Maasstadziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The participant is on the waiting list for gastric bypass surgery and is using oral venlafaxine without changes in dosages for the past four weeks.

Exclusion criteria

Exclusion criteria: Persons who have previously undergone bariatric surgery.

Design outcomes

Secondary

MeasureTime frame
Cmax, Tmax and T1/2.—

Primary

MeasureTime frame
AUC corrected for the dose—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)